Page 1

FRESENIUS MEDICAL CARE Press Release July 30 , 2021 Media Contact Matthias Link T +49 6172 609-2872 matthias.link@fmc-ag.com Contact for analysts and investors Dr. Dominik Heger T +49 6172 609-2601 dominik.heger@fmc-ag.com www.freseniusmedicalcare.com Fresenius Medical Care reports results in line with expectations for the second quarter and confirms 2021 outlook As assumed , COVID - 19 pandemic continued to impact organic growth in dialysis and downstream businesses Patient excess mortality rates significantly reduced Negative exchange rate effects continue Earnings development impacted by phasing and strong prior - year base , as indicated Financial targets for FY 2021 confirmed FME25 program on track Page 1/10 Rice Powell , Chief Executive Officer of Fresenius Medical Care , said : " The fact that we saw further easing in COVID - 19 - related excess mortality among our patients both on a monthly basis and when looking at a rolling 12 - month period - is for sure the good news we hoped for and expected to share today . We are cautious and continue to watch the Delta variant and the increasing macro - economic inflationary impacts . COVID - 19 continues to impact the number of treatments in our dialysis business , the development in our downstream businesses and the speed of closing acquisitions . As indicated in May , we saw the expected significant earnings decline in the second quarter . In addition to the current effects of the pandemic , this was due to the strong prior - year base and the reversal of the favorable phasing of costs we saw in the first quarter . Based on our defined assumptions and the business performance in the first half of the year , we confirm our outlook for the full year 2021. "